ID   UPSFRi002-A
AC   CVCL_C346
SY   PB04; PB4; UPS-FRi005-A
DR   hPSCreg; UPSFRi002-A
DR   SKIP; SKIP002387
DR   Wikidata; Q54991762
RX   PubMed=22425713;
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 16
RX   PubMed=22425713; DOI=10.1016/j.ajpath.2012.01.011;
RA   Griscelli F., Feraud O., Oudrhiri N., Gobbo E., Casal I.,
RA   Chomel J.-C., Bieche I., Duvillard P., Opolon P., Turhan A.G.,
RA   Bennaceur-Griscelli A.;
RT   "Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are
RT   revealed during in vivo differentiation of partially reprogrammed
RT   human-induced pluripotent stem cells.";
RL   Am. J. Pathol. 180:2084-2096(2012).
RX   PubMed=22514597; DOI=10.1371/journal.pone.0030743;
RA   Sandt C., Feraud O., Oudrhiri N., Bonnet M.-L., Meunier M.-C.,
RA   Valogne Y., Bertrand A., Raphael M., Griscelli F., Turhan A.G.,
RA   Dumas P., Bennaceur-Griscelli A.;
RT   "Identification of spectral modifications occurring during
RT   reprogramming of somatic cells.";
RL   PLoS ONE 7:E30743-E30743(2012).
RX   PubMed=26938212; DOI=10.1371/journal.pone.0149291;
RA   Feraud O., Valogne Y., Melkus M.W., Zhang Y.-Y., Oudrhiri N., Haddad R.,
RA   Daury A., Rocher C., Larbi A., Duquesnoy P., Divers D., Gobbo E.,
RA   Brunet de la Grange P., Louache F., Bennaceur-Griscelli A.,
RA   Mitjavila-Garcia M.-T.;
RT   "Donor dependent variations in hematopoietic differentiation among
RT   embryonic and induced pluripotent stem cell lines.";
RL   PLoS ONE 11:E0149291-E0149291(2016).